期刊文献+

细胞毒性T淋巴细胞相关抗原4编码区49位点的基因多态性与宫颈癌遗传易感性的关系 被引量:8

Association between CTLA-4 gene polymorphism and susceptibility to cervical cancer
原文传递
导出
摘要 目的探讨细胞毒性T淋巴细胞相关抗原4(CTLA-4)编码区49位点的基因多态性与宫颈癌遗传易感性的关系。方法收集314例宫颈癌患者和320例正常对照者的外周静脉血标本,应用聚合酶链反应-限制性片段长度多态性法,检测CTLA-4+49A/G多态位点的基因型。采用多因素Logistic回归法,分析基因多态性与宫颈癌发病风险的相关性以及与宫颈癌临床病理特征的关系。结果病例组中CTLA-4+49A等位基因和AA基因型的频率分别为32.5%和9.6%,对照组中分别为25.8%和5.6%。携带CTLA-4+49AA基因型者患宫颈癌的风险是GG基因型的2.06倍(95%CI为1.10—3.85,P=0.024)。CTLA-4+49基因多态与宫颈癌临床分期、病理类型、分化程度、肿瘤大小和血清鳞状上皮细胞癌抗原水平等临床病理因素均无关(均P〉0.05)。结论CTLA-4基因有可能是宫颈癌的遗传易感基因。 Objective To investigate the association between CTLA-d + 49A/G polymorphisms and the risk of susceptibility to cervical cancer. Methods A hospital-based case-control study was conducted. 314 cases with primary cervical cancer and 320 healthy controls were collected and genotyped by PCR-based RFLP for +49A/G polymorphisms in the CTLA-4 gene. Results The A allele and AA genotype of CTLA- 4 gene were 32.5% and 9.6% in the patients, and 25.8% and 5.6% in the controls, respectively. Subjects with CTLA-d + 49AA genotype conferred a higher risk of cervical cancer ( OR = 2.06,95% CI: 1.10-3.85; P = 0. 024). However, the correlation between AA genotype in CTLA-d polymorphisms and clinicopathological characteristics was not significant. Conclusion The results of this study suggest that CTLA4 gene is associated with cervical cancer risk and may be a susceptible gene of cervical cancer.
出处 《中华肿瘤杂志》 CAS CSCD 北大核心 2011年第9期681-684,共4页 Chinese Journal of Oncology
基金 教育部博士点新教师基金(20070001785)
关键词 宫颈肿瘤 细胞毒性T淋巴细胞相关抗原4 基因多态 Cervical neoplasms Cytotoxic T lymphocyte-associated antigen 4 Geneticpolymorphism
  • 相关文献

参考文献20

  • 1Ferlay JFB, Pisaniand P, Parkin DM. GLOBOCAN 2002: cancer incidence, mortality and prevalence worldwide. Lyon: IARC Press, 2004.
  • 2Donner H, Braun J, Seidl C, et al. Codon 17 polymorphism of the cytotoxic T lymphocyte antigen 4 gene in Hashimoto's thyroiditis and Addison's disease. J Clin Endocr Metab, 1997, 82:4130- 4132.
  • 3Chert L. Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity. Nat Rev Immunol, 2004, 4:336-347.
  • 4Bekkers RL, Massuger LF, Buhen J, et al. Epidemiological and clinical aspects of human papillomavirus detection in the prevention of cervical cancer. Rev Med Virol, 2004, 14:95-105.
  • 5李华,郭红燕,孙瞳,周翊峰,林东昕,章文华,乔杰.Fas和Fas配体基因启动子单核苷酸多态性与子宫颈癌的发病风险[J].中华肿瘤杂志,2009,31(1):38-41. 被引量:11
  • 6Guzman VB, Yambaltsev A, Goncalves-Primo A, et al. New approach reveals C1)28 and IFNG gene interaction in the susceptibility to cervical cancer. Hum Mol Genet, 2008, 17:1838-1844.
  • 7Sun T, Zhou Y, Yang M, et al. Functional genetic variations in cytotoxie T-lymphocyte antigen 4 and susceptibility to multiple types of cancer. Cancer Res, 2008, 68:7025-7034.
  • 8Cozar JM, Romero JM, Aptsiauri N, et al. High incidence of CTLA-4 AA ( CT60 ) polymorphism in renal cell cancer. Hum Immunol, 2007, 68:698-704.
  • 9Ghaderi A, Yeganeh F, Kalantari T, et al. Cytotoxic T lymphocyte antigen-4 gene in breast cancer. Breast Cancer Res Treat, 2004, 86:1-7.
  • 10Waterhouse P, Penninger JM, Timms E, et al. Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science, 1995, 270:985-988.

二级参考文献18

  • 1章文华,吴令英,白萍,李淑敏,张蓉,李斌,孙建衡,吴爱如.ⅠB期和ⅡA期宫颈癌患者的预后因素分析[J].中华肿瘤杂志,2004,26(8):490-492. 被引量:41
  • 2林东昕,孙瞳.单体型在肿瘤研究中的应用与展望[J].中华肿瘤杂志,2005,27(5):257-259. 被引量:5
  • 3Humlg QR, Morris D, Manolios N. Identification and characterization of polymorphisms in the promoter region of the human Apo-1/Fas (CD95) gene. Mol Immunol, 1997, 34:577-582.
  • 4Sibley K, Rollinson S, Allan JM, et al. Functional FAS promoter polymorphisms are associated with increased risk of acute myeloid leukemia. Cancer Res, 2003, 63:4327-4330.
  • 5Wu J, Metz C, Xu X, et al. A novel polymorphic CAAT/enhancerbinding protein beta element in the FasL gene promoter alters Fas ligand expression: a candidate background gene in African American systemic lupus erythematosus patients. Immunol, 2003, 170 : 132-138.
  • 6Wright TC Jr, Schiffman M, Solomon D, et al. Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening. Obstet Gynecol, 2004, 103:304- 309.
  • 7Sun T, Miao X, Zhang X, et al. Polymorphisms of death pathway genes FAS and FASL in esophageal squamous-cell carcinoma. J Natl Cancer Inst, 2004, 96:1030-1036.
  • 8Ju ST, Panka DJ, Cui H, et al. Fas( CD95 )/Fas L interactions required for programmed cell death after T-cell activation. Nature, 1995, 373:444-448.
  • 9Krammer PH. CD95's deadly mission in the immune system. Nature, 2000, 407:789-795.
  • 10Kim R, Emi M, Tanabe K, et al. The role of Fas ligand and transforming growth factor beta in tumor progression: molecular mechanisms of immune privilege via Fas-mediated apoptosis and potential targets for cancer therapy. Cancer, 2004, 100: 2281- 2291.

共引文献10

同被引文献73

  • 1杨俊英,杨海涛.应用stata软件实现logistic回归的共线性诊断[J].中国卫生统计,2005,22(3):174-176. 被引量:3
  • 2黄金双,林蓓,齐跃,周丹,张淑兰.人类白细胞抗原DRB1等位基因多态性与子宫颈癌易感性的相关性研究[J].中华妇产科杂志,2006,41(10):715-716. 被引量:6
  • 3Al-Shaikh GK, Almussaed EM, Fayed AA, et al. Knowledge of Sau- di female university students regarding cervical cancer and acceptance of the human papilloma virus vaccine[J]. Saudi Med J, 2014,35 (10) :1223-1230.
  • 4Zhao HY, Duan HX, Gu Y, Meta-analysis of the cytotoxic T- lymphocyte antigen 4 gene + 6230G/A polymorphism and cancerrlsk [ J ]. Clin Transl Oncol, 2014,16(10) :879-885.
  • 5Yan Q, Chen P, Lu A, et el. Association between CTLA-4 60G/A and -1661A/G polymorphisms and the risk of cancers: a meta-analysis [J]. PLoSOne,2013,8(12): e83710.
  • 6Vaidya B, Pearce S. The emerging role of the CTLA-4 gene in autoim- mune endocrinopathies [ J 1. Eur J Endocrinol, 2004, 150 ( 5 ) : 619-626.
  • 7Mocellin S, Nitti D. CTLA-4 blockade and the renaissance of cancer immuuotherapy [ J ]. Biochim Biophys Acta, 2013, 1836 ( 2 ) : 187-196.
  • 8Xiong YH, He L, Fei J. Genetic variations in cytotoxic T-lymphocyte antigen-4 and susceptibility to cervical cancer [ J ]. Int Immunop- harmacol, 2014,18(1 ) : 71-76.
  • 9Lee YH, Song GG. A meta-analysis of the association between CTLA- 4 +49 A/G, -318 C/T, and IL-1 polymorphisms and susceptibility to cervical cancer[ J]. Neoplasma,2014,61 (4) : 481-490.
  • 10Song A, Song J, Tang X, et al. Cooperation between CD4 and CD8 T cells for anti-tumor activity is enhanced by OX40 signals [J].Eur J Immunol, 2007, 37(5) :1224-1232.

引证文献8

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部